These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38521351)

  • 1. The influence of familial networks and stigma on prison-based medication initiation for individuals with opioid use disorder: Clinicians' perceptions.
    Rockett ML; Knudsen HK; Oser CB
    J Subst Use Addict Treat; 2024 Jul; 162():209353. PubMed ID: 38521351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
    Booty MD; Harp K; Batty E; Knudsen HK; Staton M; Oser CB
    J Subst Use Addict Treat; 2023 Jun; 149():209051. PubMed ID: 37084815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.
    Bunting AM; Oser CB; Staton M; Eddens KS; Knudsen H
    Addict Sci Clin Pract; 2018 Dec; 13(1):23. PubMed ID: 30509314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lived Experiences of Pregnant and Parenting Women in Recovery Toward Medication Treatment for Opioid Use Disorder.
    Titus-Glover D; Shaya FT; Welsh C; Roane L
    Subst Use Addctn J; 2024 Jul; 45(3):367-377. PubMed ID: 38254261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of medications for opioid use disorder and associated stigma among primary care professionals.
    Piscalko H; Dhanani LY; Brook D; Hall OT; Miller WC; Go V; Simon JE; Franz B
    Ann Med; 2024 Dec; 56(1):2399316. PubMed ID: 39234650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.
    Banta-Green CJ; Williams JR; Sears JM; Floyd AS; Tsui JI; Hoeft TJ
    Drug Alcohol Depend; 2020 Feb; 207():107799. PubMed ID: 31865058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of Community Corrections and Treatment Experience: A Qualitative Study Among People With Incarceration Histories Receiving Outpatient Methadone Treatment.
    Gaeta Gazzola M; Oberleitner LMS; Hoffman K; Eller A; Madden LM; Marcus R; Oberleitner D; Beitel M; Thompson E; Zheng X; Barry DT
    Subst Use Addctn J; 2024 Oct; 45(4):568-576. PubMed ID: 38551080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.
    Treitler PC; Enich M; Reeves D; Crystal S
    Subst Abus; 2022; 43(1):964-971. PubMed ID: 35420973
    [No Abstract]   [Full Text] [Related]  

  • 9. Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the
    Oser CB; Batty E; Booty M; Eddens K; Knudsen HK; Perry B; Rockett M; Staton M
    BMJ Open; 2023 Mar; 13(3):e066068. PubMed ID: 36940952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.
    Taylor EN; Timko C; Binswanger IA; Harris AHS; Stimmel M; Smelson D; Finlay AK
    Subst Abus; 2022; 43(1):556-563. PubMed ID: 34586978
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
    Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
    J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting.
    Lam JA; Lee HIS; Truong AQ; Macmadu A; Clarke JG; Rich J; Brockmann B
    J Subst Abuse Treat; 2019 Sep; 104():28-33. PubMed ID: 31370982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER; Powell T; Fox AD
    Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.
    Anvari MS; Kleinman MB; Massey EC; Bradley VD; Felton JW; Belcher AM; Magidson JF
    J Subst Abuse Treat; 2022 Jul; 138():108721. PubMed ID: 35067397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis.
    Couch JV; Whitcomb M; Buchheit BM; Dorr DA; Malinoski DJ; Korthuis PT; Ono SS; Levander XA
    Harm Reduct J; 2024 Jun; 21(1):125. PubMed ID: 38937779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
    JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.
    O'Grady MA; Elkington KS; Robson G; Achebe IY; Williams AR; Cohall AT; Cohall R; Christofferson M; Garcia A; Ramsey KS; Lincourt P; Tross S
    Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):12. PubMed ID: 38287329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in Medication Use for Criminal Justice System-Referred Opioid Use Disorder Treatment.
    Donahoe JT; Donohue JM; Saloner BK
    JAMA Health Forum; 2024 Sep; 5(9):e242807. PubMed ID: 39240579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.
    Sharp A; Carlson M; Howell V; Moore K; Schuman-Olivier Z
    J Subst Abuse Treat; 2021 Apr; 123():108247. PubMed ID: 33612190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.